BioSante Pharmaceuticals Inc. (BPAX) News

News for BioSante Pharmaceuticals Inc. (BPAX)

Sector News | Topic News

After Hours: $ 0.87

0.019 (+2.23%)

Volume: 41.03 k

7:02 PM EST Feb 10, 2012

Thu, Feb 09, 2012

9:00 PM

Faruqi & Faruqi, LLP Announces Investigation of BioSante Pharmaceuticals, Inc. - PR Newswire

7:55 AM

BioSante Pharmaceuticals Reports Positive LibiGel® Safety Data Review for Phase III Program - Business Wire

Wed, Feb 08, 2012

11:15 AM

BioSante Exchanges $5 Million Aggregate Principal Amount of Convertible Senior Notes for 6.7 Million Shares of Common Stock - Business Wire

Tue, Feb 07, 2012

6:47 PM

Investor Alert: Kahn Swick & Foti, LLC and Partner Former Louisiana Attorney General Remind Investors With Large Financial Interests of Lead Plaintiff Deadline in Lawsuit Against BioSante Pharmaceuticals, Inc. - Business Wire

11:37 AM

Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) - Marketwire

9:00 AM

Perception, Opportunity in Volatility - Research & Analysis on Dendreon Corporation and BioSante Pharmaceuticals, Inc. - Marketwire

Mon, Feb 06, 2012

9:05 AM

Robbins Umeda LLP Announces Class Action Suit Against BioSante Pharmaceuticals, Inc. - Business Wire

Tue, Jan 31, 2012

8:20 AM

Shares of BioSante and Cell Therapeutics on the Upswing as Biotech Sector Rallies - Marketwire

7:55 AM

BioSante Pharmaceuticals Provides Corporate Update - Business Wire

Tue, Jan 17, 2012

8:20 AM

Biotechnology Industry on the Upswing - BioSante and Cardium Therapeutics Look to Rally - Marketwire

Wed, Jan 11, 2012

6:20 PM

The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Securities Laws Violations by BioSante Pharmaceuticals, Inc. - Business Wire

6:30 AM

Robbins Umeda LLP Announces an Investigation of BioSante Pharmaceuticals, Inc. - Business Wire

Thu, Jan 05, 2012

8:16 AM

Battered Down Shares of Cell Therapeutics and BioSante Look to Rebound in 2012 - Marketwire

Wed, Dec 14, 2011

4:06 PM

BioSante Pharmaceuticals Announces Results from LibiGel® Efficacy Trials - Business Wire

Thu, Dec 01, 2011

8:16 AM

Drug Candidates From Alexza and BioSante Pharmaceuticals Inch Closer to Decision Day - Marketwire

7:00 AM

Ceregene Completes Enrollment of Second Phase 2 Study of CERE-120 for the Treatment of Parkinson's Disease - PR Newswire

Tue, Nov 29, 2011

9:00 AM

BioSante Pharmaceuticals Announces Issuance of New LibiGel® Method of Use Patent - Business Wire

Mon, Nov 21, 2011

7:55 AM

BioSante Pharmaceuticals Added to NASDAQ Biotechnology Index - Business Wire

Thu, Nov 17, 2011

8:16 AM

Cheap Valuations for Dendreon and BioSante Spark Investor Interest - Marketwire

Wed, Nov 16, 2011

7:55 AM

BioSante Pharmaceuticals Announces Positive LibiGel® Pharmacokinetic Study Results - Business Wire

Fri, Nov 04, 2011

8:16 AM

Highly Anticipated Drugs From BioSante and AEterna Zentaris May Not Be as Lucrative as Expected - Marketwire

Thu, Oct 20, 2011

8:16 AM

Late Stage Drugs From BioSante and AEterna Zentaris Could Reawaken Interest in Biotech Sector - Marketwire

Mon, Oct 10, 2011

8:25 AM

BioSante Pharmaceuticals and Sangamo Biosciences -- Aiming for Efficiency - Marketwire

Mon, Sep 19, 2011

8:27 AM

Long Term Growth Prospects From BioSante and Avanir Pharmaceuticals Remain Bright - Marketwire

Tue, Sep 06, 2011

8:16 AM

Late-Stage Products From BioSante and Keryx Gaining Momentum - Marketwire

First

1 2

Last